These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [In vitro sensitivity of Plasmodium falciparum to anti-folinic agents (trimethoprim, pyrimethamine, cycloguanil): a study of 29 African strains]. Basco LK; Le Bras J Bull Soc Pathol Exot; 1997; 90(2):90-3. PubMed ID: 9289260 [TBL] [Abstract][Full Text] [Related]
5. Molecular epidemiology of malaria in Yaounde, Cameroon. VI. Sequence variations in the Plasmodium falciparum dihydrofolate reductase-thymidylate synthase gene and in vitro resistance to pyrimethamine and cycloguanil. Basco LK; Ringwald P Am J Trop Med Hyg; 2000 Feb; 62(2):271-6. PubMed ID: 10813484 [TBL] [Abstract][Full Text] [Related]
6. Kinetic and molecular properties of the dihydrofolate reductase from pyrimethamine-sensitive and pyrimethamine-resistant clones of the human malaria parasite Plasmodium falciparum. Chen GX; Mueller C; Wendlinger M; Zolg JW Mol Pharmacol; 1987 Apr; 31(4):430-7. PubMed ID: 3553892 [TBL] [Abstract][Full Text] [Related]
7. Levels of dihydrofolate reductase and thymidylate synthetase in strains of Streptococcus faecium resistant to substituted pyrimidines, triazines and MTX. Smith CC; Freisheim JH Ann N Y Acad Sci; 1971 Nov; 186():182-4. PubMed ID: 5002296 [No Abstract] [Full Text] [Related]
8. Differences in drug response of the sporogonous cycles of three strains of Plasmodium falciparum in Anopheles stephensi. Terzian LA; Stahler N; Dawkins AT Res Commun Chem Pathol Pharmacol; 1970 Jan; 1(1):16-24. PubMed ID: 4400231 [No Abstract] [Full Text] [Related]
9. Development of 2,4-diaminopyrimidines as antimalarials based on inhibition of the S108N and C59R+S108N mutants of dihydrofolate reductase from pyrimethamine-resistant Plasmodium falciparum. Tarnchompoo B; Sirichaiwat C; Phupong W; Intaraudom C; Sirawaraporn W; Kamchonwongpaisan S; Vanichtanankul J; Thebtaranonth Y; Yuthavong Y J Med Chem; 2002 Mar; 45(6):1244-52. PubMed ID: 11881993 [TBL] [Abstract][Full Text] [Related]
10. Quantitative structure-activity relationship of antifolate inhibition of bacteria cell cultures resistant and sensitive to methotrexate. Coats EA; Genther CS; Selassie CD; Strong CD; Hansch C J Med Chem; 1985 Dec; 28(12):1910-6. PubMed ID: 3934385 [TBL] [Abstract][Full Text] [Related]
11. Mechanism of pyrimethamine resistance in recent isolates of Plasmodium falciparum. McCutchan TF; Welsh JA; Dame JB; Quakyi IA; Graves PM; Drake JC; Allegra CJ Antimicrob Agents Chemother; 1984 Nov; 26(5):656-9. PubMed ID: 6393866 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of the activities of pyrimethamine analogs against Plasmodium vivax and Plasmodium falciparum dihydrofolate reductase-thymidylate synthase using in vitro enzyme inhibition and bacterial complementation assays. Bunyarataphan S; Leartsakulpanich U; Taweechai S; Tarnchompoo B; Kamchonwongpaisan S; Yuthavong Y Antimicrob Agents Chemother; 2006 Nov; 50(11):3631-7. PubMed ID: 16954316 [TBL] [Abstract][Full Text] [Related]
13. Plasmodium falciparum: kinetic interactions of WR99210 with pyrimethamine-sensitive and pyrimethamine-resistant dihydrofolate reductase. Hekmat-Nejad M; Rathod PK Exp Parasitol; 1997 Nov; 87(3):222-8. PubMed ID: 9371087 [TBL] [Abstract][Full Text] [Related]
14. Studies concerned with overcoming resistance to methotrexate: a comparison of the effects of methotrexate and 2,4-diamino-5-(3',4'-dichlorophenyl)-6-methylpyrimidine (BW50197) on the colony forming ability of L5178Y cells. Hill BT; Goldie JH; Price LA Br J Cancer; 1973 Sep; 28(3):263-8. PubMed ID: 4743908 [TBL] [Abstract][Full Text] [Related]
15. Mutations associated with sulfadoxine-pyrimethamine and chlorproguanil resistance in Plasmodium falciparum isolates from Blantyre, Malawi. Alker AP; Mwapasa V; Purfield A; Rogerson SJ; Molyneux ME; Kamwendo DD; Tadesse E; Chaluluka E; Meshnick SR Antimicrob Agents Chemother; 2005 Sep; 49(9):3919-21. PubMed ID: 16127071 [TBL] [Abstract][Full Text] [Related]
16. Molecular dynamics of interactions between rigid and flexible antifolates and dihydrofolate reductase from pyrimethamine-sensitive and pyrimethamine-resistant Plasmodium falciparum. Mokmak W; Chunsrivirot S; Hannongbua S; Yuthavong Y; Tongsima S; Kamchonwongpaisan S Chem Biol Drug Des; 2014 Oct; 84(4):450-61. PubMed ID: 24716467 [TBL] [Abstract][Full Text] [Related]
17. The mechanism of pyrimethamine resistance in Plasmodium falciparum. Dieckmann A; Jung A Parasitology; 1986 Oct; 93 ( Pt 2)():275-8. PubMed ID: 3537922 [TBL] [Abstract][Full Text] [Related]
18. Recombinant Plasmodium falciparum dihydrofolate reductase-based in vitro screen for antifolate antimalarials. Brobey RK; Sano G; Itoh F; Aso K; Kimura M; Mitamura T; Horii T Mol Biochem Parasitol; 1996 Oct; 81(2):225-37. PubMed ID: 8898337 [TBL] [Abstract][Full Text] [Related]
19. Point mutations in the dihydrofolate reductase and dihydropteroate synthetase genes and in vitro susceptibility to pyrimethamine and cycloguanil of Plasmodium falciparum isolates from Papua New Guinea. Reeder JC; Rieckmann KH; Genton B; Lorry K; Wines B; Cowman AF Am J Trop Med Hyg; 1996 Aug; 55(2):209-13. PubMed ID: 8780462 [TBL] [Abstract][Full Text] [Related]
20. Similar trends of pyrimethamine resistance-associated mutations in Plasmodium vivax and P. falciparum. Alam MT; Bora H; Bharti PK; Saifi MA; Das MK; Dev V; Kumar A; Singh N; Dash AP; Das B; Wajihullah ; Sharma YD Antimicrob Agents Chemother; 2007 Mar; 51(3):857-63. PubMed ID: 17194833 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]